BCLP advises two U.S. investment funds, OrbiMed Advisors and Deerfield, on a $40 million follow-on financing agreement with Valneva

Insights /

News

May 24, 2022

English

Paris, 9th May 2022 – Bryan Cave Leighton Paisner (BCLP) has advised two U.S. healthcare investment funds, Orbimed Advisors and Deerfield Management Company, in a $40 million follow-on financing agreement with vaccine company Valneva.

This agreement completes an initial agreement of February 2020 between the above two funds and Valneva by increasing the amount in principal of the 2020 agreement.

Orbimed Advisors and Deerfield Management Company were advised in France by Bryan Cave Leighton Paisner (BCLP) Paris with a team composed of Corporate Partner Christian Sauer, Partner Olivier Borenstejn and Associate Aliou Wone in financing. In the US the investment funds were advised by Covington & Burling LLP.

Valneva was advised in France by Hogan Lovells (Paris) LLP. The Hogan Lovells team was composed of Jean Marc Franceschi, Corporate Partner, Sophie Lok, Counsel, Ouassila El Asri and Diane Ferriol, Financing Associates. In the US, Valneva was advised by Dechert LLP.

Meet The Team

Olivier Borenstejn

Paris

+33 (0) 1 44 17 77 04

Meet The Team

Olivier Borenstejn

Paris

+33 (0) 1 44 17 77 04

Meet The Team

Olivier Borenstejn

Paris

+33 (0) 1 44 17 77 04

This material is not comprehensive, is for informational purposes only, and is not legal advice. Your use or receipt of this material does not create an attorney-client relationship between us. If you require legal advice, you should consult an attorney regarding your particular circumstances. The choice of a lawyer is an important decision and should not be based solely upon advertisements. This material may be “Attorney Advertising” under the ethics and professional rules of certain jurisdictions. For advertising purposes, St. Louis, Missouri, is designated BCLP’s principal office and Kathrine Dixon (kathrine.dixon@bclplaw.com) as the responsible attorney.